Gain Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $82 |
Gross Profit | -22 | -2,722 | -2,223 | -21 |
EBITDA | -4,712 | -5,085 | -4,364 | -3,242 |
EBIT | -4,735 | -5,094 | -4,374 | -3,263 |
Net Income | -5,284 | -5,809 | -4,530 | -3,768 |
Net Change In Cash | 0 | 0 | 0 | 82 |
Free Cash Flow | -4,926 | -5,098 | -3,821 | -3,455 |
Cash | 8,807 | 6,694 | 9,070 | 10,385 |
Basic Shares | 34,998 | 30,341 | 28,685 | 27,132 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $55 | $132 | $133 |
Gross Profit | -84 | 55 | -8,110 | -7,030 |
EBITDA | -20,266 | -22,169 | -17,760 | -13,822 |
EBIT | -20,350 | -22,253 | -17,787 | -13,837 |
Net Income | -20,411 | -22,267 | -17,590 | -13,890 |
Net Change In Cash | 0 | 55 | 132 | 133 |
Cost of Revenue | -29,545 | |||
Free Cash Flow | -18,896 | -18,881 | -14,811 | -12,459 |
Cash | 10,385 | 11,794 | 7,311 | 36,880 |
Basic Shares | 22,881 | 13,011 | 11,883 | 10,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.15 |
2025-06-30 | -$0.19 |
2025-03-31 | -$0.16 |
2024-12-31 | -$0.08 |
